Article
Effectiveness of Colonoscopy for Colorectal Cancer Screening in Reducing Cancer-Related Mortality: Interpreting the Results From Two Ongoing Randomized Trials
- Author:
- Daniel Isaac, DO, MS
Article
Trastuzumab Deruxtecan in HER2-Positive Breast Cancer
- Author:
- Daniel Isaac, DO, MS
Article
Overall Survival Gain With Adding Darolutamide to ADT and Docetaxel in Metastatic, Hormone-Sensitive Prostate Cancer
- Author:
- Santosh Kagathur, MD
- Daniel Isaac, DO, MS
Article
Adjuvant Olaparib Improves Outcomes in High-Risk, HER2-Negative Early Breast Cancer Patients With Germline BRCA1 and BRCA2 Mutations
- Author:
- Mahmoud Abdelsamia, MD
- Daniel Isaac, DO, MS
Article
Nivolumab Plus Cabozantinib Improves Outcomes Compared With Sunitinib for Advanced Renal Cell Carcinoma
- Author:
- Daniel Isaac, DO, MS
- Osama Mosalem, MD
Article
Avelumab Maintenance Therapy Improves Survival in Metastatic Urothelial Carcinoma
- Author:
- Daniel Isaac, DO, MS
Article
Pembrolizumab Plus Neoadjuvant Chemotherapy Improves Pathologic Complete Response Rates in Triple-Negative Breast Cancer
- Author:
- Daniel Isaac, DO, MS
Article
Cabazitaxel Improves Progression-Free and Overall Survival in Metastatic Prostate Cancer After Progression on Abiraterone or Enzalutamide
- Author:
- Britni Souther, DO
- Daniel Isaac, DO, MS
Article
Combination Encorafenib, Cetuximab, and Binimetinib Improves Survival in BRAF V600E–Mutated Metastatic Colon Cancer
- Author:
- Daniel Isaac, DO, MS
Article
Enzalutamide Improves Progression-Free and Overall Survival in Metastatic Hormone-Sensitive Prostate Cancer
- Author:
- Daniel Isaac, DO, MS
Article
Combination of Ibrutinib and Rituximab Prolongs Progression-Free Survival in Waldenström Macroglobulinemia
- Author:
- Daniel Isaac, DO, MS
Article
Adjuvant Pembrolizumab Improves Progression-Free Survival in Stage III Melanoma
- Author:
- Daniel Isaac, DO, MS
Article
CAR T-Cell Therapy Shows High Levels of Durable Response in Refractory Large B-Cell Lymphoma
- Author:
- Daniel Isaac, DO, MS
Article
Brentuximab Vedotin with Chemotherapy Improves Progression-Free Survival in Advanced-Stage Hodgkin’s Lymphoma
- Author:
- Daniel Isaac, DO, MS
Article
Addition of Durvalumab After Chemoradiotherapy Improves Progression-Free Survival in Unresectable Stage III Non-Small-Cell Lung Cancer
- Author:
- Daniel Isaac, DO, MS